Literature DB >> 24231664

Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Tammy L Sirich1, Benjamin A Funk, Natalie S Plummer, Thomas H Hostetter, Timothy W Meyer.   

Abstract

Dialytic clearance of urea is efficient, but other small solutes normally secreted by the kidney may be cleared less efficiently. This study tested whether the high concentrations of these solutes in hemodialysis patients reflect a failure of passive diffusion methods to duplicate the efficacy of clearance by tubular secretion. We compared the plasma concentrations and clearance rates of four solutes normally cleared by tubular secretion with the plasma concentrations and clearance rates of urea and creatinine in patients receiving maintenance hemodialysis and normal subjects. The predialysis concentrations (relative to normal subjects) of unbound phenylacetylglutamine (122-fold), hippurate (108-fold), indoxyl sulfate (116-fold), and p-cresol sulfate (41-fold) were much greater than the concentrations of urea (5-fold) and creatinine (13-fold). The dialytic clearance rates (relative to normal subjects) of unbound phenylacetylglutamine (0.37-fold), hippurate (0.16-fold), indoxyl sulfate (0.21-fold), and p-cresol sulfate (0.39-fold) were much lower than the rates of urea (4.2-fold) and creatinine (1.3-fold). Mathematical modeling showed that prominent accumulation of the normally secreted solutes in hemodialysis patients could be accounted for by lower dialytic clearance relative to physiologic clearance combined with the intermittency of treatment. Whether or not more efficient removal of normally secreted solutes improves outcomes in dialysis patients remains to be tested.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24231664      PMCID: PMC3935591          DOI: 10.1681/ASN.2013060597

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

Review 1.  RENAL FUNCTION IN CHRONIC RENAL DISEASE.

Authors:  N S BRICKER; S KLAHR; H LUBOWITZ; R E RIESELBACH
Journal:  Medicine (Baltimore)       Date:  1965-07       Impact factor: 1.889

2.  Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.

Authors:  G Mingrone; R De Smet; A V Greco; A Bertuzzi; A Gandolfi; S Ringoir; R Vanholder
Journal:  Clin Chim Acta       Date:  1997-04-04       Impact factor: 3.786

Review 3.  Impaired binding of drugs and endogenous ligands in renal diseases.

Authors:  P F Gulyassy; T A Depner
Journal:  Am J Kidney Dis       Date:  1983-05       Impact factor: 8.860

4.  Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.

Authors:  G Lesaffer; R De Smet; N Lameire; A Dhondt; P Duym; R Vanholder
Journal:  Nephrol Dial Transplant       Date:  2000-01       Impact factor: 5.992

5.  Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers.

Authors:  Robert B MacArthur; Arman Altincatal; Mendel Tuchman
Journal:  Mol Genet Metab       Date:  2004-04       Impact factor: 4.797

Review 6.  Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

Authors:  Johan W Jonker; Alfred H Schinkel
Journal:  J Pharmacol Exp Ther       Date:  2003-10-23       Impact factor: 4.030

7.  Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.

Authors:  Ruben Poesen; Liesbeth Viaene; Kristin Verbeke; Kathleen Claes; Bert Bammens; Ben Sprangers; Maarten Naesens; Yves Vanrenterghem; Dirk Kuypers; Pieter Evenepoel; Björn Meijers
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

8.  Effect of diet on serum accumulation and renal excretion of aryl acids and secretory activity in normal and uremic man.

Authors:  W Cathcart-Rake; R Porter; F Whittier; P Stein; M Carey; J Grantham
Journal:  Am J Clin Nutr       Date:  1975-10       Impact factor: 7.045

9.  Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes.

Authors:  Timothy W Meyer; Evonne C Leeper; Derek W Bartlett; Thomas A Depner; Yiming Zhao Lit; Channing R Robertson; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

Review 10.  Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure.

Authors:  T Niwa
Journal:  Semin Nephrol       Date:  1996-05       Impact factor: 5.299

View more
  61 in total

Review 1.  Kt/V (and especially its modifications) remains a useful measure of hemodialysis dose.

Authors:  John T Daugirdas
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

2.  Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.

Authors:  Tariq Shafi; Tammy L Sirich; Timothy W Meyer; Thomas H Hostetter; Natalie S Plummer; Seungyoung Hwang; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  Kidney Int       Date:  2017-07-21       Impact factor: 10.612

3.  Assessing Clinical Relevance of Uremic Toxins.

Authors:  Jennifer E Flythe; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-21       Impact factor: 8.237

Review 4.  Microbiota issue in CKD: how promising are gut-targeted approaches?

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Alice Sabatino; Enrico Fiaccadori; Biagio Raffaele Di Iorio; Loreto Gesualdo
Journal:  J Nephrol       Date:  2018-08-01       Impact factor: 3.902

5.  Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.

Authors:  Matthew B Rivara; Leila R Zelnick; Andrew N Hoofnagle; Rick Newitt; Russell P Tracy; Mario Kratz; David S Weigle; Bryan R Kestenbaum
Journal:  Clin Chem       Date:  2017-02-10       Impact factor: 8.327

6.  Can oral therapy reduce uremic toxins?

Authors:  Thomas A Depner; Larry D Cowgill
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 8.237

7.  Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.

Authors:  Sheldon C Leong; Justin N Sao; Abigail Taussig; Natalie S Plummer; Timothy W Meyer; Tammy L Sirich
Journal:  J Am Soc Nephrol       Date:  2018-05-04       Impact factor: 10.121

Review 8.  Approaches to uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

Review 9.  Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.

Authors:  David A Drew; Daniel E Weiner; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

10.  Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis.

Authors:  Manjula Kurella Tamura; Glenn M Chertow; Thomas A Depner; Allen R Nissenson; Brigitte Schiller; Ravindra L Mehta; Sai Liu; Tammy L Sirich
Journal:  J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.